ARTICLE | Financial News
Icos nicked on inconclusive FSAD trial
June 18, 2001 7:00 AM UTC
ICOS was off $3.18 to $59.56 on Monday after Lilly Icos, a joint venture between Eli Lilly (LLY) and ICOS, announced after market close on Friday that IC351 showed no conclusive treatment effect compa...